发明名称 Oxa(thia)zolidine compounds, process for preparation thereof and anti-inflammatory agents
摘要 The present invention provides medicinal compositions characterized by comprising as the active ingredient either a compound represented by a formula [I] or a pharmaceutically acceptable composite thereof; [wherein X represents oxygen or sulfur; R<SUB>1 </SUB>represents e.g., C<SUB>1-4 </SUB>alkyl, phenyl optionally substituted, etc.; Q<SUB>1 </SUB>represents spacer consisted of 0 to 3 carbon atoms; R<SUB>2 </SUB>represents, e.g., phenyl optionally substituted; R<SUB>3 </SUB>represents, e.g., hydrogen, C<SUB>1-4 </SUB>alkyl, or a group represented by the following formulae; -CONH-R<SUB>6</SUB>; R<SUB>4 </SUB>and R<SUB>5 </SUB>represent e.g., nitro, cyano, C<SUB>1-4 </SUB>alkylcarbonyl, respectively]; in particular, medicine which is useful as therapeutic and/or protective drugs for inflammatory diseases and/or allergic diseases by improving sick conditions accompanied with the stimulated phospholipase A(2) activity.
申请公布号 US7189751(B2) 申请公布日期 2007.03.13
申请号 US20030482231 申请日期 2003.12.19
申请人 NIPPON SODA CO., LTD. 发明人 TAKAGI MASAE;NISHIBE TADAYUKI;ISHIMITSU KEIICHI
分类号 A61K31/42;A61K31/421;A61K31/422;A61K31/426;A61K31/427;A61K31/4439;A61P1/00;A61P1/16;A61P9/10;A61P11/00;A61P11/02;A61P11/06;A61P13/12;A61P17/00;A61P17/06;A61P17/16;A61P19/02;A61P25/28;A61P29/00;A61P31/04;A61P37/02;A61P37/08;A61P43/00;C07D263/02;C07D263/10;C07D263/14;C07D263/16;C07D277/10;C07D277/12;C07D277/16;C07D413/04;C07D413/06;C07D417/04;C07D417/06;C07D417/12 主分类号 A61K31/42
代理机构 代理人
主权项
地址